Chairman
Acurx Pharmaceuticals, Inc. (ACXP)Equibles does not estimate personal net worth.
Get an email with a short summary when Acurx Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ACXP alertsRobert DeLuccia is recorded as Chairman at Acurx Pharmaceuticals, Inc. (ACXP). The newest filing on record that lists Robert DeLuccia as Chairman at Acurx Pharmaceuticals, Inc. (ACXP) is dated September 1, 2026. The proxy statement of Acurx Pharmaceuticals, Inc. reports total compensation of $1,463,430 for Robert DeLuccia in fiscal 2024, including a base salary of $539,172. Disclosed compensation is on record for 5 fiscal years. Robert DeLuccia has spoken on 3 earnings calls across 1 company, most recently for Acurx Pharmaceuticals, Inc. on May 15, 2024. Acurx Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acurx Pharmaceuticals, Inc. includes David P. Luci (CEO and Board Member), Carl V. Sailer (Board Member), Jack H. Dean (Board Member) and 3 others.
“So let me just add a few thoughts on top of Dave's comments about our end of Phase 2 meeting with the FDA. In general, it was a very thorough, productive, and successful meeting regarding four things.”
“Thanks Dave and Rob for updating our stakeholders and thanks to all for the continuing support as we advance ibezapolstat into Phase III clinical trials.”
“I want to thank all for your continuing support to reach this important clinical development milestone, which takes ibezapolstat one step closer to commercialization for CDI patients in need of a promising new antibiotic with a novel bactericidal mechanism of action.”
Start not stated–present
Last confirmed September 1, 2026
Biotechnology · Healthcare
Chairman
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Acurx Pharmaceuticals, Inc. (ACXP) | Executive Chairman | $539,172 | $1,463,430 |
| 2023 | Acurx Pharmaceuticals, Inc. (ACXP) | Executive Chairman | $485,000 | $1,056,436 |
| 2022 | Acurx Pharmaceuticals, Inc. (ACXP) | Executive Chairman | $475,000 | $677,186 |
| 2021 | Acurx Pharmaceuticals, Inc. (ACXP) | Executive Chairman | $363,500 | $4,509,094 |
| 2020 | Acurx Pharmaceuticals, Inc. (ACXP) | Executive Chairman | $277,000 | $617,570 |
